This legislation aims to enhance the regulation of laboratory developed tests (LDTs) under the Clinical Laboratory Improvement Amendments (CLIA), ensuring that these tests are safe, effective, and scientifically valid for clinical use. The goal is to protect patients while fostering innovation in laboratory practices. Key provisions include a clear definition of LDTs, establishing standards for both analytical and clinical validity. Laboratories must demonstrate that their tests provide accurate and reliable information for diagnosing or monitoring health conditions.